Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis: Pathophysiological and Clinical Implications. Pilot Study.

NCT01810965 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT01810965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01810965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis: Pathophysiological and Clinical Implications. Pilot Study.
Lead sponsor
Rennes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 3, 2013
Completion date
April 19, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemochromatosis type 1